The effect of CDK4 inhibitor to AML

被引:0
|
作者
wang, Jie [1 ]
机构
[1] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA
来源
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:62 / 62
页数:1
相关论文
共 50 条
  • [32] Cracking the Genomic Code of CDK4/6 Inhibitor Resistance
    Wander, Seth A.
    Bardia, Aditya
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2008 - 2010
  • [33] Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
    Chen, Fengquan
    Liu, Chunxi
    Zhang, Jian
    Xu, Wenfang
    Zhang, Yingjie
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (09) : 1241 - 1251
  • [34] Clinical development of CDK4/6 inhibitor for breast cancer
    Iwata, Hiroji
    BREAST CANCER, 2018, 25 (04) : 402 - 406
  • [35] FDA approves Novartis's CDK4/6 inhibitor
    Mullard A.
    Nature Reviews Drug Discovery, 2017, 16 (4) : 229 - 229
  • [36] MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma
    Bustos, Matias A.
    Ono, Shigeshi
    Marzese, Diego M.
    Oyama, Takashi
    Iida, Yuuki
    Cheung, Garrett
    Nelson, Nellie
    Hsu, Sandy C.
    Yu, Qiang
    Hoon, Dave S. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (09) : 1955 - 1964
  • [37] Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor
    Makiko Kobayashi
    Ikuko Takahashi-Suzuki
    Toshiyasu Shimomura
    Yoshikazu Iwasawa
    Hiroshi Hirai
    Investigational New Drugs, 2011, 29 : 921 - 931
  • [38] Regulation of CDK4
    Bockstaele, Laurence
    Coulonval, Katia
    Kooken, Hugues
    Paternot, Sabine
    Roger, Pierre P.
    CELL DIVISION, 2006, 1 (1)
  • [39] Regulation of CDK4
    Laurence Bockstaele
    Katia Coulonval
    Hugues Kooken
    Sabine Paternot
    Pierre P Roger
    Cell Division, 1
  • [40] Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor
    Kobayashi, Makiko
    Takahashi-Suzuki, Ikuko
    Shimomura, Toshiyasu
    Iwasawa, Yoshikazu
    Hirai, Hiroshi
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 921 - 931